159 related articles for article (PubMed ID: 36184996)
1. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Elmali A; Yilmaz MT; Koc I; Deliktas O; Gumeler E; Cengiz M; Zorlu F
Radiother Oncol; 2022 Nov; 176():39-45. PubMed ID: 36184996
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Cengiz M; Tarlan B; Mocan BO; Zorlu F
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):152-158. PubMed ID: 28586956
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma.
Kosydar S; Robertson JC; Woodfin M; Mayr NA; Sahgal A; Timmerman RD; Lo SS
Am J Clin Oncol; 2021 Jan; 44(1):32-42. PubMed ID: 33208706
[TBL] [Abstract][Full Text] [Related]
4. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
5. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Muller K; Nowak PJ; de Pan C; Marijnissen JP; Paridaens DA; Levendag P; Luyten GP
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):116-22. PubMed ID: 16111579
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for medium and large uveal melanoma with a non-invasive eye immobilization device, a single institutional case series.
Tsui MC; Chia-Hsien Cheng J; Lin CP
J Formos Med Assoc; 2023 Nov; 122(11):1117-1124. PubMed ID: 37258323
[TBL] [Abstract][Full Text] [Related]
9. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
10. Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma.
van Beek JGM; Ramdas WD; Angi M; van Rij CM; Naus NC; Kacperek A; Errington RD; Damato B; Heimann H; Kiliç E
Radiother Oncol; 2021 Apr; 157():219-224. PubMed ID: 33549643
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic radiotherapy for uveal melanoma: Long-term outcome and control rates.
van Beek JGM; van Rij CM; Baart SJ; Yavuzyigitoglu S; Bergmann MJ; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2022 Aug; 100(5):511-519. PubMed ID: 34529346
[TBL] [Abstract][Full Text] [Related]
12. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
14. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
15. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
[TBL] [Abstract][Full Text] [Related]
17. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
18. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
19. One-day session LINAC-based stereotactic radiosurgery of posterior uveal melanoma.
Furdova A; Strmen P; Waczulikova I; Chorvath M; Sramka M; Slezak P
Eur J Ophthalmol; 2012; 22(2):226-35. PubMed ID: 21534252
[TBL] [Abstract][Full Text] [Related]
20. Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma.
Laliscia C; Genovesi-Ebert F; Perrone F; Guido F; Cresti F; Fuentes T; Coccia N; Mattioni R; Morganti R; Paiar F
Anticancer Res; 2022 Apr; 42(4):1965-1972. PubMed ID: 35347016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
